Over the last ten years, the treatment of seronegative spondyloarthropathies has changed dramatically with the introduction of the anti-tumor necrosis factor alpha (TNFα) agents. Nevertheless, there is a growing number of studies describing several adverse reactions in patients treated with biological agents. In the present report we describe the case of a 22-year-old male patient with ankylosing spondylitis who developed a “paradoxic” adverse reaction, while receiving infliximab.
Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab / Gutierrez, Marwin Saady; Becciolini, A; Bertolazzi, C; DI GESO, Luca; Tardella, M; Ariani, A; Filippucci, Emilio; Grassi, Walter. - In: REUMATISMO. - ISSN 0048-7449. - 62/2010:(2010), pp. 221-224.
Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab
GUTIERREZ, Marwin Saady;DI GESO, LUCA;FILIPPUCCI, Emilio;GRASSI, Walter
2010-01-01
Abstract
Over the last ten years, the treatment of seronegative spondyloarthropathies has changed dramatically with the introduction of the anti-tumor necrosis factor alpha (TNFα) agents. Nevertheless, there is a growing number of studies describing several adverse reactions in patients treated with biological agents. In the present report we describe the case of a 22-year-old male patient with ankylosing spondylitis who developed a “paradoxic” adverse reaction, while receiving infliximab.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
